Home' Australian Pharmacist : Australian Pharmacist February 2016 Contents Australian Pharmacist February 2016 I ©Pharmaceutical Society of Australia Ltd.
Creating a career in the
BY ANDREW DANIELS
The potential roles for pharmacists working in GP clinics keep expanding,
according to clinical pharmacist Radhika Somasundaram.
Radhika has been working as part of
the healthcare team at the Mt Druitt
Medical Centre, which includes five GPs,
a dietitian, an exercise physiologist and
psychologists, for the past two years.
She believes the patient-centred medical
home concept being promoted by the
Royal Australian College of General
Practitioners (RACGP) and which is being
implemented at Mt Druitt will increase
the opportunities for pharmacists to
establish a place in the healthcare team.
While working as an NPS MedicineWise
facilitator, Radhika met Dr Kean-Seng
Lim, who owns the Mt Druitt Medical
Centre (see Australian Pharmacist,
December 2015, page 17, A pharmacist's
place is in the medical home). Dr Kean
was recently named as the 2015 RACGP
General Practitioner of the Year.
'Dr Kean was interested in further
implementing the proper vetting of
prescribing habits in his GP practice,'
Radhika told Australian Pharmacist.
'We had chat and he said "why don't you
come on board?".
'He wanted to see whether a pharmacist
in a GP practice could help general
practice nurses improve their prescribing
habits and improve patient adherence
and patient health literacy, because in
the area we work in Western Sydney
health literacy is not that great.'
They worked together for six months
and then collected data on their progress
which showed that prescribers were
prescribing medications better, the
assessment of frail elderly patients
was better, and de-prescribing of
their medication was likely to happen
Radhika said: 'The greatest benefit I think
we have seen is in the de-prescribing side
of things where the pharmacist started
a conversation with the patient and
then with the GP consultation we were
able to drop unnecessary medications
thereby preventing hospital admissions,
early nursing home placements,
improving the morbidity and decreasing
the mortality rates as well.
'There is good evidence for that. We saw
that patient adherence improved
having a pharmacist on board. We used
questionnaires to assess each patient's
adherence. Then we implemented
interventions that would improve
adherence. We would get them back
after a month or so and reassess them.
That improved the adherence of
The feedback from patients, practice
nurses and GPs was positive.
Patients said it was great to have
someone available to ask questions
about their medicines, and where
patients were taking multiple
medications that had not been reviewed
in a long time, to potentially reduce their
Ego defends Sunsense
We condemn claims made by Choice
that a SunSense product didn't meet its
SPF claims. After independent retesting
of the same batch, SunSense Sport SPF
50+ has returned results with an SPF
greater than 60.
When Choice contacted us to say
they were sending their results to the
media we immediately commissioned
retesting on the identified batch at an
independent FDA accredited laboratory
which is well respected for providing
reliable and consistent results.
The results were received today,
which returned an SPF greater than
60, both static and post immersion,
which also supports its four hours
water resistance claim (immersion was
not tested by Choice). This supports
the certification for SunSense Sport
SPF 50+ that is held in support of our
registration with the Therapeutic Goods
Administration (TGA) and unequivocally
counteracts these recent claims.
These independent results are
consistent with the vast number of
SPF tests that were conducted during
our product development. SPF testing
is a highly specialised form of clinical
testing so it's very important to have
consistency and reproducibility.
Our world class A1 rated manufacturing
facility in Australia is licensed by the
TGA. All of our sunscreen manufacturing
methods are fully validated in
compliance with the requirements of
Good Manufacturing Practice (GMP).
This ensures the quality and reproducibility
of our processes to prevent any risk of
changes between batches.
Australia has one of the highest
incidences of skin cancer in the world and
reports like this are extremely concerning
as it is imperative that Australians are not
discouraged from using sunscreen to
protect against UV damage.
We stand by our SPF claims. You and
your customers can be assured that the
quality of Ego's products is not in any
way compromised. We are for healthy
skin, first and foremost and we support
Dr Kerryn Greive (PhD)
Scientific Affairs Manager Ego Pharmaceuticals
Dr Jane Oppenheim (PhD)
Scientific & Operations Director Ego Pharmaceuticals
LETTERS TO THE EDITOR
Letters are invited from anyone wishing to
comment on articles or issues relevant to
pharmacy. However, any letters judged by the
Editor to be potentially defamatory will not
be published. Letters should be no more than
300 words long. They can be emailed to the Editor
Links Archive Australian Pharmacist January 2016 Australian Pharmacist March 2016 Navigation Previous Page Next Page